Geode Capital Management’s Anika Therapeutics ANIK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.4M Sell
321,211
-8,787
-3% -$93K ﹤0.01% 2928
2025
Q1
$4.96M Buy
329,998
+7,220
+2% +$109K ﹤0.01% 2659
2024
Q4
$5.31M Sell
322,778
-2,186
-0.7% -$36K ﹤0.01% 2721
2024
Q3
$8.03M Sell
324,964
-16,104
-5% -$398K ﹤0.01% 2497
2024
Q2
$8.64M Buy
341,068
+11,905
+4% +$302K ﹤0.01% 2413
2024
Q1
$8.36M Buy
329,163
+10,250
+3% +$260K ﹤0.01% 2432
2023
Q4
$7.23M Buy
318,913
+13,053
+4% +$296K ﹤0.01% 2507
2023
Q3
$5.7M Buy
305,860
+10,978
+4% +$205K ﹤0.01% 2576
2023
Q2
$7.66M Buy
294,882
+10,217
+4% +$265K ﹤0.01% 2455
2023
Q1
$8.18M Buy
284,665
+9,043
+3% +$260K ﹤0.01% 2382
2022
Q4
$8.16M Buy
275,622
+11,421
+4% +$338K ﹤0.01% 2390
2022
Q3
$6.29M Buy
264,201
+2,879
+1% +$68.5K ﹤0.01% 2548
2022
Q2
$5.83M Buy
261,322
+7,742
+3% +$173K ﹤0.01% 2618
2022
Q1
$6.37M Sell
253,580
-5,813
-2% -$146K ﹤0.01% 2649
2021
Q4
$9.29M Buy
259,393
+730
+0.3% +$26.2K ﹤0.01% 2488
2021
Q3
$11M Buy
258,663
+3,613
+1% +$154K ﹤0.01% 2389
2021
Q2
$11M Buy
255,050
+12,637
+5% +$547K ﹤0.01% 2391
2021
Q1
$9.89M Buy
242,413
+29,412
+14% +$1.2M ﹤0.01% 2380
2020
Q4
$9.64M Buy
213,001
+3,889
+2% +$176K ﹤0.01% 2207
2020
Q3
$7.4M Sell
209,112
-23,017
-10% -$815K ﹤0.01% 2153
2020
Q2
$8.76M Buy
232,129
+18,362
+9% +$693K ﹤0.01% 2003
2020
Q1
$6.18M Sell
213,767
-9,087
-4% -$263K ﹤0.01% 2014
2019
Q4
$11.6M Buy
222,854
+2,332
+1% +$121K ﹤0.01% 1912
2019
Q3
$12.1M Buy
220,522
+1,836
+0.8% +$101K ﹤0.01% 1811
2019
Q2
$8.88M Buy
218,686
+21,032
+11% +$854K ﹤0.01% 2037
2019
Q1
$5.98M Buy
197,654
+19,420
+11% +$587K ﹤0.01% 2225
2018
Q4
$5.99M Buy
178,234
+6,329
+4% +$213K ﹤0.01% 2105
2018
Q3
$7.25M Buy
171,905
+4,391
+3% +$185K ﹤0.01% 2137
2018
Q2
$5.36M Buy
167,514
+28,036
+20% +$897K ﹤0.01% 2282
2018
Q1
$6.93M Buy
139,478
+3,010
+2% +$150K ﹤0.01% 2030
2017
Q4
$7.36M Buy
136,468
+3,906
+3% +$211K ﹤0.01% 1962
2017
Q3
$7.69M Buy
132,562
+7,649
+6% +$444K ﹤0.01% 1921
2017
Q2
$6.16M Buy
124,913
+7,877
+7% +$389K ﹤0.01% 2013
2017
Q1
$5.08M Sell
117,036
-3,128
-3% -$136K ﹤0.01% 2098
2016
Q4
$5.88M Sell
120,164
-3,454
-3% -$169K ﹤0.01% 1958
2016
Q3
$5.91M Buy
123,618
+11,774
+11% +$563K ﹤0.01% 1855
2016
Q2
$6M Buy
111,844
+3,225
+3% +$173K ﹤0.01% 1790
2016
Q1
$4.86K Buy
108,619
+13,126
+14% +$587 ﹤0.01% 1890
2015
Q4
$3.64M Buy
95,493
+1,773
+2% +$67.7K ﹤0.01% 2098
2015
Q3
$2.98M Buy
93,720
+810
+0.9% +$25.8K ﹤0.01% 2172
2015
Q2
$3.07M Buy
92,910
+6,077
+7% +$201K ﹤0.01% 2234
2015
Q1
$3.57M Buy
86,833
+12,218
+16% +$503K ﹤0.01% 2058
2014
Q4
$3.04M Sell
74,615
-9,051
-11% -$369K ﹤0.01% 2144
2014
Q3
$3.07M Buy
83,666
+943
+1% +$34.6K ﹤0.01% 2096
2014
Q2
$3.83M Buy
82,723
+9,116
+12% +$422K ﹤0.01% 1953
2014
Q1
$3.03M Sell
73,607
-35,829
-33% -$1.47M ﹤0.01% 2090
2013
Q4
$4.18M Buy
109,436
+55,132
+102% +$2.1M ﹤0.01% 1836
2013
Q3
$1.3M Buy
54,304
+2,782
+5% +$66.7K ﹤0.01% 2450
2013
Q2
$876K Buy
+51,522
New +$876K ﹤0.01% 2542